Who owns the ELIXIRGEN THERAPEUTICS trademark?

The ELIXIRGEN THERAPEUTICS trademark is owned by Elixirgen Therapeutics, Inc..

What is the serial number for ELIXIRGEN THERAPEUTICS?

The USPTO serial number for ELIXIRGEN THERAPEUTICS is 97150514.

What is the registration number for ELIXIRGEN THERAPEUTICS?

ELIXIRGEN THERAPEUTICS is registered under USPTO registration number 7950350.

ELI

USPTO Trademark Record

REGISTERED

ELIXIRGEN THERAPEUTICS

Q: What class is the ELIXIRGEN THERAPEUTICS trademark registered in?

The ELIXIRGEN THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 97150514·Reg 7950350·Filed Dec 01, 2021

Owner Elixirgen Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ELIXIRGEN THERAPEUTICS (Serial No. 97150514), Registration No. 7950350, is a registered US trademark filed on Dec 01, 2021 by Elixirgen Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

early section 8: September 16, 2031

Mark Intelligence

ELIXIRGEN THERAPEUTICS (Reg. #7950350) is a registered US trademark that has been protecting its owner, Elixirgen Therapeutics, Inc., since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 01, 2021

SERIAL

97150514

REG#

7950350

REGISTERED

Sep 16, 2025

Owner

Applicant

Elixirgen Therapeutics, Inc.

Entity

Corporation

State

Address

855 N. Wolfe St., Suite 624, Baltimore, MD, 21205

Country

Attorney

NameLeonard D. Bowersox

Law firm

Leonard D. Bowersox KILYK & BOWERSOX, P.L.L.C.

Docket

3190-250

Address

3925 CHAIN BRIDGE RD., SUITE D-401, FAIRFAX, VA 22030, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateDec 01, 2021

Serial Number97150514

Registration No.7950350

Registration DateSep 16, 2025

Status DateSep 16, 2025

Published for OppositionJan 09, 2024

Mark TypeDesign with words

Attorney Docket3190-250

Status DescriptionLive and registered

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jul 06, 2023

First use in commerce: Jul 06, 2023

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Oct 15, 2022

First use in commerce: Oct 15, 2022

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

33 events

REGISTERED-PRINCIPAL REGISTER

Sep 16, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Sep 16, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 26, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Aug 26, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 25, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 25, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

DIVISIONAL PROCESSING COMPLETE

Sep 04, 2024

DIVISIONAL PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Sep 04, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 21, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 02, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

SU - NON-FINAL ACTION - WRITTEN

Aug 02, 2024

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Aug 02, 2024

NON-FINAL ACTION E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 12, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Apr 12, 2024

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Mar 22, 2024

TEAS STATEMENT OF USE RECEIVED

DIVISIONAL REQUEST RECEIVED

Mar 22, 2024

DIVISIONAL REQUEST RECEIVED

TEAS REQUEST TO DIVIDE RECEIVED

Mar 22, 2024

TEAS REQUEST TO DIVIDE RECEIVED

USE AMENDMENT FILED

Mar 22, 2024

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 05, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jan 09, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 09, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 20, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 04, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 03, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 03, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 03, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Sep 19, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Sep 19, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 19, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Sep 10, 2022

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Dec 07, 2021

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 06, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 04, 2021

NEW APPLICATION ENTERED

ELIXIRGEN THERAPEUTICS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Elixirgen Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Leonard D. Bowersox

Resources

Company